Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
‘You not only know us, you love and trust us:’ How J&J spinoff Kenvue is raising its profile
Medical Marketing and Media
Mon, 06/26/23 - 08:37 pm
JNJ
spinoffs
Kenvue
consumer health
GE HealthCare partners with J&J to push spine imaging system
Medtech Dive
Thu, 06/22/23 - 11:31 am
Medtech
GE Healthcare
JNJ
DePuy Synthes
spine imaging
OEC 3D Imaging System
J&J, Deloitte launch Illustrate Change, a library of diverse medical images
Medical Marketing and Media
Tue, 06/20/23 - 09:52 pm
JNJ
Deloitte
medical images
Abbott’s $1.9B electrophysiology unit threatened by pulsed field ablation: analysts
Medtech Dive
Tue, 06/13/23 - 10:54 pm
Medtech
Abbott Labs
pulsed field ablation
JNJ
Medtronic
Boston Scientific
EHA 2023: Janssen’s talquetamab shows promise in multiple myeloma
Clinical Trials Arena
Tue, 06/13/23 - 10:39 am
talquetamab
JNJ
Multiple Myeloma
Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva
Fierce Pharma
Mon, 06/12/23 - 11:36 pm
JNJ
Stelara
biosimilars
legal
patents
Teva Pharmaceutical
Alvotech
Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement
BioSpace
Mon, 06/12/23 - 10:15 am
opioids
opioid crisis
legal
pharmacies
McKesson
AmerisourceBergen
Cardinal Health
Teva Pharmaceutical
AbbVie
JNJ
Alkermes, after arbitration win over J&J, jacks up revenue forecast by $425M
Fierce Pharma
Wed, 06/7/23 - 10:18 am
Alkermes
JNJ
nanocrystals
Abiomed heart pump recall labeled Class I by FDA, no deaths reported
Medtech Dive
Tue, 06/6/23 - 09:55 am
JNJ
Abiomed
devices
Medtech
Impella 5.5
product recalls
device recalls
ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial
Fierce Pharma
Mon, 06/5/23 - 10:02 pm
ASCO 2023
JNJ
Balversa
bladder cancer
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Johnson & Johnson cites rebates and discounts for drug price increases
Fierce Pharma
Mon, 05/29/23 - 12:09 pm
JNJ
drug pricing
drug rebates
drug discounts
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
Thu, 05/25/23 - 12:48 pm
JNJ
Janssen
Tremfya
psoriasis
real world data
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
Tue, 05/23/23 - 06:14 pm
JNJ
Amgen
patents
Stelara
biosimilars
legal
J&J beats back Viatris' generic challenge to schizophrenia med Invega Trinza
Fierce Pharma
Thu, 05/18/23 - 11:16 am
JNJ
schizophrenia
generics
Trinza
Viatris
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
FDA
drug approvals
accelerated approvals
AbbVie
AstraZeneca
Bayer
Bristol Myers Squibb
JNJ
Merck
Merck KGaA
Novartis
Pfizer
Janssen’s Tremyfa scores success in Phase III ulcerative colitis trial
Clinical Trials Arena
Wed, 05/10/23 - 10:02 am
JNJ
Janssen
clinical trials
Tremyfa
ulcerative colitis
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Motley Fool
Mon, 05/8/23 - 11:46 pm
JNJ
consumer health
spinoffs
Kenvue
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »